Loading
Total declarations
Companies
▲ Purchases (51 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2026 for Orchestra BioMed Holdings, Inc., €16k.
Filing timeline
BuySaleDavid P. Hochman
Insider track record
Disclosed buys
51
Disclosed sells
0
Signal history
Closed purchases
Market purchases
51
Positive at T+90
33%
Median T+90
-5.0%
Based on 33 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +0.4%Entry US$5.45 · Close 22 Oct 2026 US$5.47
- +18.7%Entry US$4.61 · Close 22 Oct 2026 US$5.47
- +29.3%Entry US$4.23 · Close 22 Oct 2026 US$5.47
- +75.3%Entry US$3.00 · Close at T+365 US$5.26
- +58.1%Entry US$2.67 · Close at T+365 US$4.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David P. Hochman: trading record in brief
David P. Hochman (board member) discloses dealings in 5 companies, chiefly Orchestra BioMed Holdings, Inc., Corbus Pharmaceuticals Holdings, Inc. and Motus GI Holdings, Inc. We count 105 filings; the first trade dates from 18 May 2006 and the latest from 10 September 2026.
The open-market record is one-sided, with 51 purchases worth €1.4M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 37 share grants and 5 option exercises. Since January 2026: 2 purchases and no sales on the market.
In size, the median ticket on the buying side is €12k. On 16 out of 31 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 33 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -5.0%. These figures describe past trades and do not predict future prices.
The record was last updated on 11 September 2026 with a share grant (€16k) in Orchestra BioMed Holdings, Inc. The most recent open-market purchase was published on 8 September 2026, 46 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David P. Hochman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations99 total
3,283 shares@ US$5.810.0056% mcap1.6% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-107143:0
10,000 shares@ US$4.790.013% mcap3.9% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-105690:0
Canonical exit: 2 Dec 2026 (T+90)
32,438 shares@ US$4.5712.2% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-036162:0
10,000 shares@ US$4.293.6% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-028554:0
Canonical exit: 11 Jun 2026 (T+90)
504,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-015318:0
3,283 shares@ US$4.671.2% of flowCommon StockSEC:0001104659-25-120659:1
40,355 shares@ US$4.6715.5% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-120659:0
5,000 shares@ US$4.071.7% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-113235:0
Canonical exit: 12 Feb 2026 (T+90)
3,283 shares@ US$4.181.1% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-112699:0
3,283 shares@ US$2.460.6% of flowCommon StockSEC:0001104659-25-091742:1
40,355 shares@ US$2.468.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-091742:0
6,000 shares@ US$2.491.2% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-082635:0
Canonical exit: 19 Nov 2025 (T+90)
100,000 shares0Common StockSEC:0001104659-25-075782:1
100,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075782:0
20,000 shares@ US$2.754.5% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-073743:0
Canonical exit: 2 Nov 2025 (T+90)
5,671 shares@ US$3.141.4% of flowCommon StockSEC:0001104659-25-059416:1
34,038 shares@ US$3.148.9% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-059416:0
98,333 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-032334:0
80,080 shares@ US$4.2330.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-021856:0
4,000 shares@ US$4.661.7% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-131767:0
Canonical exit: 23 Mar 2025 (T+90)
5,000 shares@ US$4.912.2% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-130007:0
Canonical exit: 18 Mar 2025 (T+90)
1,500 shares@ US$4.860.6% of flowCommon StockSEC:0001104659-24-103002:1
Canonical exit: 24 Dec 2024 (T+90)
2,000 shares@ US$4.740.8% of flowCommon StockSEC:0001104659-24-103002:2
Canonical exit: 24 Dec 2024 (T+90)
2,000 shares@ US$4.700.7% of flowCommon StockSEC:0001104659-24-103002:3
Canonical exit: 24 Dec 2024 (T+90)
2,000 shares@ US$4.730.8% of flowCommon StockSEC:0001104659-24-103002:4
Canonical exit: 24 Dec 2024 (T+90)
25 of 99 declarations
